Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-08

Clinical Trial Update: Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing co-administration of LDX (SPD489) with venlafaxine XR in healthy volunteers; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LDX (lisdexamfetamine)
  • Venlafaxine XR (venlafaxine)

Snippet

Sponsor: Shire | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2011-12-08